Stock Events

Stock Events

Imunon 

$1.6000
79
+$0.00+0% Friday 20:00
+$0.00+0%Friday 21:48After hours

Statistics

Day High
1.58
Day Low
1.58
52W High
6.14
52W Low
1.47
Volume
1,033
Avg. Volume
-
Mkt Cap
8.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-5.25
-3.58
-1.92
-0.25
Expected EPS
-0.552
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-14.5MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMNN. It's not an investment recommendation.
NVIDIA
9
NVDA
Amazon
7
AMZN
AMD
6
AMD
Visa
6
V

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences is a biopharmaceutical company that competes with Imunon in the development of treatments for infectious diseases, including HIV and hepatitis, areas where Imunon also aims to innovate.
Merck
MRK
Mkt Cap376.37B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including cancer treatments and vaccines, directly competing with Imunon's focus on oncology and immunotherapy.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb operates in the same biopharmaceutical space as Imunon, focusing on cancer, HIV/AIDS, cardiovascular disease, and immune disorders, making it a direct competitor.
AMGEN
AMGN
Mkt Cap237.52B
Amgen is a biotech company focusing on human therapeutics, including treatments for cancer and inflammatory diseases, competing with Imunon's research and development in similar areas.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a global pharmaceutical corporation that competes with Imunon in the development and marketing of drugs and vaccines for a wide range of diseases, including those targeted by Imunon's pipeline.
Novartis
NVS
Mkt Cap301.95B
Novartis is a global healthcare company that competes with Imunon in developing innovative medicines for various diseases, including cancer and autoimmune diseases, areas of focus for Imunon.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Imunon in the fields of pharmaceuticals and diagnostics, particularly in oncology and immunology.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie is a research-based biopharmaceutical company that competes with Imunon in developing therapies for complex and serious diseases, including cancer and immune-mediated diseases.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson is a diversified healthcare company that competes with Imunon across several areas, including pharmaceuticals and research and development in immunology and oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious medical conditions, competing with Imunon in the area of immunotherapy and targeted cancer treatments.

About

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
Show more...
CEO
Stacy R. Lindborg
Employees
20
Country
United States
ISIN
US15117N7012
WKN
000A41CNR

Listings

STU
DE
CBO0.STU
MU
DE
CBO0.MU
F
DE
CBO0.F
LSE
GB
0HUZ.LSE

0 Comments

Share your thoughts

FAQ

What is Imunon stock price today?▼
The current price of IMNN is $1.60 USD — it has increased by +0% in the past 24 hours. Watch Imunon stock price performance more closely on the chart.
What is Imunon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Imunon stocks are traded under the ticker IMNN.
Is Imunon stock price growing?▼
IMNN stock has fallen by -2.44% compared to the previous week, the month change is a +3.9% rise, over the last year Imunon has showed a -73.02% decrease.
What is Imunon market cap?▼
Today Imunon has the market capitalization of 8.98M
When is the next Imunon earnings date?▼
Imunon is going to release the next earnings report on November 16, 2026.
What were Imunon earnings last quarter?▼
IMNN earnings for the last quarter are -0.54 USD per share, whereas the estimation was -0.87 USD resulting in a +37.75% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Imunon revenue for the last year?▼
Imunon revenue for the last year amounts to 0 USD.
What is Imunon net income for the last year?▼
IMNN net income for the last year is -14.5M USD.
How many employees does Imunon have?▼
As of August 29, 2026, the company has 20 employees.
In which sector is Imunon located?▼
Imunon operates in the Health & Wellness sector.
When did Imunon complete a stock split?▼
The last stock split for Imunon was on August 07, 2025 with a ratio of 1.15:1.
Where is Imunon headquartered?▼
Imunon is headquartered in LAWRENCEVILLE, United States.